Related references
Note: Only part of the references are listed.Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring
Elena A. Govorkova et al.
ANTIVIRAL RESEARCH (2013)
Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics
Sachiko Seo et al.
ANTIVIRAL THERAPY (2013)
T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
Tatiana Baranovich et al.
JOURNAL OF VIROLOGY (2013)
The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews
Barbara Michiels et al.
PLOS ONE (2013)
Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice
E. Bart Tarbet et al.
ANTIVIRAL RESEARCH (2012)
Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections
Vanessa Escuret et al.
ANTIVIRAL RESEARCH (2012)
Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents
Donald F. Smee et al.
ANTIVIRAL RESEARCH (2012)
Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households
Fabrice Carrat et al.
ANTIVIRAL THERAPY (2012)
Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses
Jack T. Nguyen et al.
PLOS ONE (2012)
Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice
Donald F. Smee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses
Katrina Sleeman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro
Larisa V. Gubareva et al.
ANTIVIRAL THERAPY (2010)
Adaptation of Pandemic H1N1 Influenza Viruses in Mice
Natalia A. Ilyushina et al.
JOURNAL OF VIROLOGY (2010)
T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
Maki Kiso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Combination Chemotherapy for Influenza
Elena A. Govorkova et al.
VIRUSES-BASEL (2010)
Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on Influenza A (H5N1) Virus Infections in Cell Culture and in Mice
Donald F. Smee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus
Thanyada Rungrotmongkol et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The resurgence of swine-origin influenza A (H1N1)
Sherif Beniameen Mossad
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Nila J. Dharan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007-08 Season
Adam Meijer et al.
EMERGING INFECTIOUS DISEASES (2009)
Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice
Natalia A. Ilyushina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Widespread Oseltamivir Resistance in Influenza A Viruses (H1N1), South Africa
Terry G. Besselaar et al.
EMERGING INFECTIOUS DISEASES (2008)
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide
Varough M. Deyde et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Efficacy of orally administered T-705 on lethal avian influenza a (H5N1) virus infections in mice
Robert W. Sidwell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants
Natalia A. Ilyushina et al.
ANTIVIRAL RESEARCH (2006)
Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection
MG Ison et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Mechanism of action of T-705 against influenza virus
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
JAL Ives et al.
ANTIVIRAL RESEARCH (2002)
Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo
J Carr et al.
ANTIVIRAL RESEARCH (2002)
In vitro and in vivo activities of anti-influenza virus compound T-705
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
